P PRIMESTOCKFINDER.COM

EL8 Shares Elevate Uranium Ltd

ASX · ASX
$0.21 +10.53% Prices as of close 2026-10-27

Last in our picks 2026-10-02 — not in the current list; analysis below is from that screen

Uranium exposure with strong sector momentum and rerating potential.

Future value: $0.53 (+152.38%) · 6-12 months

  • ▸Uranium momentum and institutional interest.
  • ▾Below 50-day MA (-16.67%)
  • ▾Near 52-week low (2.6% of range)
  • ▸~152% upside to price target

Trend: EL8 is trading below the 50-day average (-12.50%), RSI 49 — neutral momentum, with a 3-month return of -6.67%.

Valuation & quality: Elevate Uranium Ltd trades on PEG 1.75, price-to-book 2.76; fundamentals show net margin 0.0%, return on equity -52.9%.

Analyst consensus: 1 analysts have a mean 12-month price target of A$1.03 (+390.5% vs the last close; range A$1.03 – A$1.03), consensus rating “none”.

Our screen: BUY (score 3) — Uranium exposure with strong sector momentum and rerating potential.

Computed from end-of-day data; not personal advice.

0.38 0.19 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.19 – 0.38.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
-18.90%-6.70%-10.70%-12.00%+0.00%+22.70%-25.90%+5.00%
Market cap
$99.0M
EPS (ttm)
$-0.04
Price / book
2.76
PEG
1.75
Beta
1.16
Net margin
0.0%
ROE
-52.9%
Revenue (ttm)
$50,000
Free cash flow
$-12,129,501
Debt / equity
1%
52-wk range
$0.19 – $0.49
Volume
812,275
Avg volume (3m)
809,665
Mean target
$1.03
Low
$1.03
High
$1.03
Analysts
1
Consensus
NONE
RSI (14)
48.7
vs 50-day MA
-12.50%
1-mo return
-6.67%
3-mo return
-6.67%
Volume z-score
-0.45

Elevate Uranium Ltd engages in the exploration and evaluation of uranium deposits in Namibia and Australia. Its flagship project is the 100% owned Koppies project located in the Namib Desert region, Namibia.

Sector: Energy · Industry: Uranium · Australia · Website

Browse: all ASX stocks · Energy picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.